Global Antisense Oligonucleotides Market Growth (Status and Outlook) 2023-2029

Global Antisense Oligonucleotides Market Growth (Status and Outlook) 2023-2029

Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein.

LPI (LP Information)' newest research report, the “Antisense Oligonucleotides Industry Forecast” looks at past sales and reviews total world Antisense Oligonucleotides sales in 2022, providing a comprehensive analysis by region and market sector of projected Antisense Oligonucleotides sales for 2023 through 2029. With Antisense Oligonucleotides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antisense Oligonucleotides industry.

This Insight Report provides a comprehensive analysis of the global Antisense Oligonucleotides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antisense Oligonucleotides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antisense Oligonucleotides market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antisense Oligonucleotides and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antisense Oligonucleotides.

The global Antisense Oligonucleotides market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Antisense Oligonucleotides is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Antisense Oligonucleotides is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Antisense Oligonucleotides is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Antisense Oligonucleotides players cover Ionis Pharmaceuticals, Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Antisense Therapeutics, Isarna Therapeutics, Arrowhead Pharmaceuticals, Atlantic Pharmaceuticals and Enzon Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Antisense Oligonucleotides market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
RNA Antisense Oligonucleotides
DNA Antisense Oligonucleotides

Segmentation by application
Hospitals
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ionis Pharmaceuticals
Sarepta Therapeutics
Biogen
Alnylam Pharmaceuticals
Antisense Therapeutics
Isarna Therapeutics
Arrowhead Pharmaceuticals
Atlantic Pharmaceuticals
Enzon Pharmaceuticals
Bio-Path Holdings
GlaxoSmithKline
Geron
ICO Therapeutics
Marina Biotech
RXi Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.